Cannabis Comes Into the Light at the End of a Long Tunnel
Clin Ther. 2023 Jun;45(6):483-485. doi: 10.1016/j.clinthera.2023.04.015. NO ABSTRACT PMID:37414497 | DOI:10.1016/j.clinthera.2023.04.015...
A Research Agenda to Inform Cannabis Regulation: How Science Can Shape Policy
Clin Ther. 2023 Jun;45(6):506-514. doi: 10.1016/j.clinthera.2023.03.010. ABSTRACT In the United States, changes to cannabis policy have outpaced scientific knowledge about cannabis, its effects, and the...
History of Cannabis Regulation and Medicinal Therapeutics: It’s Complicated
Clin Ther. 2023 Jun;45(6):521-526. doi: 10.1016/j.clinthera.2023.04.011. ABSTRACT The genus Cannabis has a complex history, with great variations in the genus itself, as well as in...
Medicinal Cannabis Guidance and Resources for Health Professionals to Inform Clinical Decision Making
Clin Ther. 2023 Jun;45(6):527-534. doi: 10.1016/j.clinthera.2023.03.007. ABSTRACT PURPOSE: Interest in the use of cannabis as a medicine has markedly increased during the last decade, with...
Self-reported Medicinal Cannabis Use as an Alternative to Prescription and Over-the-counter Medication Use Among US Military Veterans
Clin Ther. 2023 Jun;45(6):562-577. doi: 10.1016/j.clinthera.2023.04.003. ABSTRACT BACKGROUND: Mental and other physical health concerns and substance use disorder are common and co-occurring events experienced by...
Monoacylglycerol lipase protects the presynaptic cannabinoid 1 receptor from desensitization by endocannabinoids after persistent inflammation
J Neurosci. 2023 Jul 5:JN-RM-0037-23. doi: 10.1523/JNEUROSCI.0037-23.2023. Online ahead of print. ABSTRACT Cannabinoid-targeted pain therapies are increasing with the expansion of cannabis legalization, however, their...
Under the umbrella of depression and Alzheimer’s disease physiopathology: can cannabinoids be a dual-pleiotropic therapy?
Ageing Res Rev. 2023 Jul 4:101998. doi: 10.1016/j.arr.2023.101998. Online ahead of print. ABSTRACT Depression and Alzheimer´s disease (AD) are two disorders highly prevalent worldwide. Depression...
Tobacco/nicotine dependence as a risk factor for substance use disorders and related mental health conditions among cancer patients
Psychooncology. 2023 Jul 6. doi: 10.1002/pon.6190. Online ahead of print. ABSTRACT BACKGROUND: Cancer patients often face multiple comorbidities and are at risk for various mental...
Prenatal Substance Use Among Young Pregnant Sexual Minority People
LGBT Health. 2023 Jul 6. doi: 10.1089/lgbt.2023.0026. Online ahead of print. ABSTRACT Purpose: Sexual minority (SM) youth have higher rates of substance use and pregnancy...
Sustainable production of Saussurea costus under different levels of nitrogen, phosphorus and potassium fertilizers in cold desert region of Western Himalaya
Front Plant Sci. 2023 Jun 20;14:1179183. doi: 10.3389/fpls.2023.1179183. eCollection 2023. ABSTRACT INTRODUCTION: Saussurea costus, an important critically endangered medicinal herb native to the Himalayan region,...
Cannabinoid Signaling in Kidney Disease
Cells. 2023 May 18;12(10):1419. doi: 10.3390/cells12101419. ABSTRACT Endocannabinoid signaling plays crucial roles in human physiology in the function of multiple systems. The two cannabinoid receptors,...
Applying the theory of planned behavior to predict online addiction treatment intention
J Addict Dis. 2023 Jul 6:1-8. doi: 10.1080/10550887.2023.2230834. Online ahead of print. ABSTRACT METHODS: This descriptive-analytical study included a self-report questionnaire based on the TPB...
Co-occurring mental health and drug use experiences among Black and Hispanic/Latino sexual and gender diverse individuals
J Behav Med. 2023 Jul 6. doi: 10.1007/s10865-023-00433-7. Online ahead of print. ABSTRACT Black and Hispanic/Latino sexual and gender diverse individuals disproportionately experience overlapping health...
Cannabinoids: Emerging sleep modulator
Biomed Pharmacother. 2023 Jul 3;165:115102. doi: 10.1016/j.biopha.2023.115102. Online ahead of print. ABSTRACT Sleep is an essential biological phase of our daily life cycle and is...
Equal remission rates and reduced length of hospital stay with twice-daily repetitive transcranial magnetic stimulation (rTMS) for major depression – A large naturalistic retrospective cohort association study
Prog Neuropsychopharmacol Biol Psychiatry. 2023 Jul 3:110820. doi: 10.1016/j.pnpbp.2023.110820. Online ahead of print. ABSTRACT OBJECTIVES: Repetitive transcranial magnetic stimulation (rTMS) is a level 1a evidence-based...